Episode 02 – Top 5 Trends in the Pharmaceutical Industry Part 2
Welcome to the Vast Value A Podcast by Vamstar. This episode is part 2 of continuing the discussion started in our blog on The Top 5 trends that will shape the Pharmaceutical Industry in 2021 and beyond. Be sure to check out the original blog and our other articles on the Pharma industry!
Stay tuned for more insightful content coming soon! Be sure to follow us on social media @Vamstar, to stay up-to-date on all things Vast Value and Vamstar!
Do you have any feedback or suggested topics? Pleaser each out to us at hello@vamstar.io, We would love to hear from you!
About the speakers
Soumitra Sharma
VP of Pharmaceutical Practices at Vamstar
Soumitra is Harvard Business School alumni, with 17+ years of corporate strategy & management consulting experience focused in healthcare sector.
Specializing in health economics, pricing analytics, volume-based procurement, tender strategy, market intelligence, forecasting, Go-To-Market, market access, funding, licensing, portfolio management etc. Worked across cultures with specialisation in key markets of Asia, Middle East, and Europe.
Praful Mehta
CEO and Co-founder of Vamstar
Praful Mehta is the co-founder and CEO of Vamstar. He has more than 16 years of experience in helping pharmaceutical and medical device companies create effective commercialisation strategies across different therapeutic areas. Mr. Mehta has been a longtime advisor to senior teams on the issues of market access strategies, sourcing and procurement, launch planning, landscape assessments, market competitiveness, and lifecycle planning. He has significant project experience in working with the BRIC-MT and EU-5 nations, as well as the United States and Japan. Mr. Mehta has been interviewed and quoted in various journals, print media, blogs and leadership forums within the industry. Prior to working at Vamstar, Mr. Mehta was a Senior Principal at IHS Markit, where he developed the company’s core market access, pricing and reimbursement, and forecasting capability for different healthcare markets. Mr. Mehta also led various project teams at GlaxoSmithKline Pharmaceuticals and Johnson & Johnson.
